Cereius is developing innovative next-generation targeted radiotherapeutics for cancer patients.
Member count: 11-50
Total raised: $6.75M
Founded date: 2017

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
25.07.2018-$6.75MBioInnovat...citybizlis...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
26.07.2018Biotechnol...Cereius, Inc., a Durham, NC-ba...USA-finsmes.co...
25.07.2018BioInnovat...Cereius, Inc., a biotechnology...--citybizlis...
25.07.2018Cereius Ra...Cereius, Inc., a biotechnology...--citybizlis...